ASO Visual Abstract: The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy
Titel:
ASO Visual Abstract: The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy
Auteur:
Blumencranz, Peter Habibi, Mehran Shivers, Steve Acs, Geza Blumencranz, Lisa E. Yoder, Erin B. van der Baan, Bastiaan Menicucci, Andrea R. Dauer, Patricia Audeh, William Cox, Charles E.